Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer

Clinical trial NCT00574275 · TERMINATED

Trial details

NCT number: NCT00574275
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Neoplasm

Start date: 2007-12-01
Primary completion: 2009-10-01
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.